Key stats
About ISHARES IV PLC - NASDAQ US BIOTECHNOLOGY UCITS ETF
Home page
Inception date
Mar 6, 2018
Structure
Irish VCIC
Replication method
Physical
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BDZVHG35
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.86%
Health Technology97.42%
Commercial Services1.21%
Technology Services0.72%
Health Services0.49%
Process Industries0.02%
Bonds, Cash & Other0.14%
Cash0.14%
Stock breakdown by region
North America84.93%
Europe14.66%
Asia0.37%
Oceania0.04%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history